Skip to main content

Advertisement

Table 1 Clinicopathologic characteristics of patients with NSCLC who had undergone complete resection

From: Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer

Variables No. of subjects (n = 429)
Gender  
   Male 324 (75.5%)
   Female 105 (24.5%)
Age (median, years) 62 (range: 26-81)
Tumor size (median, cm) 3.8 (range: 0.8-20)
Type of surgical resection*  
   Pneumonectomy 70 (16.4%)
   Bilobectomy 32 (7.5%)
   Lobectomy 319 (74.7%)
   Limited resection 6 (1.4%)
Clinical stage  
   I 221 (51.5%)
   II 102 (23.8%)
   III 106 (24.7%)
Adjuvant therapy**  
   Chemotherapy only 68 (15.9%)
   Radiotherapy only 104 (24.2%)
   Neither 184 (42.9%)
   Both 71 (16.6%)
Median follow-up period (mean ± SD, months) 65.8(56.3 ± 33.9)
Recurrent cases (recurrence rate) 170 (39.6%)
  1. * Information on the type of surgical resection was not available in two cases.
  2. ** Information on radiotherapy was not available in two of the cases treated with chemotherapy.